S&P 500   4,538.43
DOW   34,580.08
QQQ   383.13
S&P 500   4,538.43
DOW   34,580.08
QQQ   383.13
S&P 500   4,538.43
DOW   34,580.08
QQQ   383.13
S&P 500   4,538.43
DOW   34,580.08
QQQ   383.13
NYSEARCA:BIS

ProShares UltraShort Nasdaq Biotechnology Stock Forecast, Price & News

$21.63
+0.91 (+4.39%)
(As of 12/3/2021 12:00 AM ET)
Add
Today's Range
$20.28
$21.78
50-Day Range
$17.01
$21.63
52-Week Range
$15.86
$25.70
Volume
22,883 shs
Average Volume
39,798 shs
Market Capitalization
$7.48 million
P/E Ratio
N/A
Dividend Yield
0.00%
Beta
N/A
30 days | 90 days | 365 days | Advanced Chart
Receive BIS News and Ratings via Email

Sign-up to receive the latest news and ratings for ProShares UltraShort Nasdaq Biotechnology and its competitors with MarketBeat's FREE daily newsletter.

Basic Details

Issuer ProShares
Fund NameProShares UltraShort Nasdaq Biotechnology
Tax ClassificationRegulated Investment Company
SymbolNYSEARCA:BIS
Inception Date4/6/2010
Fund ManagerMichael Neches, Tarak Dave
WebN/A
PhoneN/A

Fund Focus

Asset ClassEquity
BenchmarkNasdaq Biotech Index
CategorySector
FocusHealth Care
Development LevelDeveloped Markets
RegionNorth America

Fund Statistics

Assets Under Management$7.16 million
Average Daily Volume$11.38 thousand
Discount/Premium0.04%

ETF Expenses

Management Fee0.75%
Other Expenses0.80%
Total Expenses1.55%
Fee Waiver-0.60%
Net Expenses0.95%

Administrator, Advisor and Custodian

AdministratorJ.P. Morgan Investor Services Co.
AdvisorProShare Advisors LLC
CustodianJPMorgan Chase Bank, N.A.
DistributorSEI Investments Distribution Co.
Transfer AgentJPMorgan Chase Bank, N.A.
Trustee
Lead Market MakerIMC Chicago

Currency Exposure of BIS













ProShares UltraShort Nasdaq Biotechnology (NYSEARCA:BIS) Frequently Asked Questions

What other stocks do shareholders of ProShares UltraShort Nasdaq Biotechnology own?

Based on aggregate information from My MarketBeat watchlists, some companies that other ProShares UltraShort Nasdaq Biotechnology investors own include Galapagos (GLPG), VanEck Vectors Biotech ETF (BBH), Virtus LifeSci Biotech Clinical Trials ETF (BBC), Boeing (BA), EKIMAS (ASNB), ARK Genomic Revolution Multi-Sector ETF (ARKG), Aphria (APHQF), (APHA), Acasti Pharma (ACST) and Aclaris Therapeutics (ACRS).

What is ProShares UltraShort Nasdaq Biotechnology's stock symbol?

ProShares UltraShort Nasdaq Biotechnology trades on the New York Stock Exchange (NYSE)ARCA under the ticker symbol "BIS."

How do I buy shares of ProShares UltraShort Nasdaq Biotechnology?

Shares of BIS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is ProShares UltraShort Nasdaq Biotechnology's stock price today?

One share of BIS stock can currently be purchased for approximately $21.63.

How much money does ProShares UltraShort Nasdaq Biotechnology make?

ProShares UltraShort Nasdaq Biotechnology has a market capitalization of $7.48 million.


This page was last updated on 12/4/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.